132 related articles for article (PubMed ID: 7821331)
1. Neuron damage induced by some potent kainoids and neuroprotective action of new agonists for metabotropic glutamate receptors.
Shinozaki H
Eur Neurol; 1994; 34 Suppl 3():2-9. PubMed ID: 7821331
[TBL] [Abstract][Full Text] [Related]
2. Anticonvulsive and neuroprotective actions of a potent agonist (DCG-IV) for group II metabotropic glutamate receptors against intraventricular kainate in the rat.
Miyamoto M; Ishida M; Shinozaki H
Neuroscience; 1997 Mar; 77(1):131-40. PubMed ID: 9044381
[TBL] [Abstract][Full Text] [Related]
3. Specific lesions of rat spinal interneurons induced by systemic administration of acromelic acid, a new potent kainate analogue.
Shinozaki H; Ishida M; Gotoh Y; Kwak S
Brain Res; 1989 Dec; 503(2):330-3. PubMed ID: 2557968
[TBL] [Abstract][Full Text] [Related]
4. Neurotoxicity of (2S,1'R,2'R,3'R)-2-(2,3-dicarboxycyclopropyl)glycine, a potent agonist for class II metabotropic glutamate receptors, in the rat.
Kwak S; Miyamoto M; Ishida M; Shinozaki H
Neuroscience; 1996 Aug; 73(3):687-95. PubMed ID: 8809790
[TBL] [Abstract][Full Text] [Related]
5. Acromelic acid, a novel kainate analogue, induces long-lasting paraparesis with selective degeneration of interneurons in the rat spinal cord.
Shin K; Hitoshi A; Michiko I; Haruhiko S
Exp Neurol; 1992 May; 116(2):145-55. PubMed ID: 1577122
[TBL] [Abstract][Full Text] [Related]
6. Neuroprotection by metabotropic glutamate receptor agonists on kainate-induced degeneration of motor neurons in spinal cord slices from adult rat.
Pizzi M; Benarese M; Boroni F; Goffi F; Valerio A; Spano PF
Neuropharmacology; 2000 Mar; 39(5):903-10. PubMed ID: 10699456
[TBL] [Abstract][Full Text] [Related]
7. Selective degeneration of inhibitory interneurons in the rat spinal cord induced by intrathecal infusion of acromelic acid.
Kwak S; Nakamura R
Brain Res; 1995 Dec; 702(1-2):61-71. PubMed ID: 8846097
[TBL] [Abstract][Full Text] [Related]
8. Systemic administration of acromelic acid induces selective neuron damage in the rat spinal cord.
Kwak S; Aizawa H; Ishida M; Shinozaki H
Life Sci; 1991; 49(14):PL91-6. PubMed ID: 1890926
[TBL] [Abstract][Full Text] [Related]
9. [Neuron damage in the rat spinal cord induced by acromelic acid].
Shin K
Rinsho Shinkeigaku; 1991 Dec; 31(12):1313-5. PubMed ID: 1817797
[TBL] [Abstract][Full Text] [Related]
10. Novel kainate derivatives: potent depolarizing actions on spinal motoneurones and dorsal root fibres in newborn rats.
Ishida M; Shinozaki H
Br J Pharmacol; 1991 Dec; 104(4):873-8. PubMed ID: 1687368
[TBL] [Abstract][Full Text] [Related]
11. Spinal cord mGlu1a receptors: possible target for amyotrophic lateral sclerosis therapy.
Valerio A; Ferrario M; Paterlini M; Liberini P; Moretto G; Cairns NJ; Pizzi M; Spano P
Pharmacol Biochem Behav; 2002 Sep; 73(2):447-54. PubMed ID: 12117600
[TBL] [Abstract][Full Text] [Related]
12. Ceftriaxone-mediated upregulation of the glutamate transporter GLT-1 contrasts neurotoxicity evoked by kainate in rat organotypic spinal cord cultures.
Bajrektarevic D; Nistri A
Neurotoxicology; 2017 May; 60():34-41. PubMed ID: 28257918
[TBL] [Abstract][Full Text] [Related]
13. Neurotoxicity of acromelic acid in cultured neurons from rat spinal cord.
Tsuji K; Nakamura Y; Ogata T; Mitani A; Kataoka K; Shibata T; Ishida M; Shinozaki H
Neuroscience; 1995 Sep; 68(2):585-91. PubMed ID: 7477968
[TBL] [Abstract][Full Text] [Related]
14. Systemic administration of domoic acid-induced spinal cord lesions in neonatal rats.
Wang GJ; Schmued LC; Andrews AM; Scallet AC; Slikker W; Binienda Z
J Spinal Cord Med; 2000; 23(1):31-9. PubMed ID: 10752872
[TBL] [Abstract][Full Text] [Related]
15. [Pharmacology of the glutamate receptor].
Shinozaki H
Nihon Yakurigaku Zasshi; 2000 Sep; 116(3):125-31. PubMed ID: 11031741
[TBL] [Abstract][Full Text] [Related]
16. Actions of LY341495 on metabotropic glutamate receptor-mediated responses in the neonatal rat spinal cord.
Howson PA; Jane DE
Br J Pharmacol; 2003 May; 139(1):147-55. PubMed ID: 12746233
[TBL] [Abstract][Full Text] [Related]
17. [Excitatory amino acids and neuronal death].
Shinozaki H
No To Hattatsu; 1995 Mar; 27(2):104-12. PubMed ID: 7727152
[TBL] [Abstract][Full Text] [Related]
18. Role of group II and III metabotropic glutamate receptors in rhythmic patterns of the neonatal rat spinal cord in vitro.
Taccola G; Marchetti C; Nistri A
Exp Brain Res; 2004 Jun; 156(4):495-504. PubMed ID: 15007577
[TBL] [Abstract][Full Text] [Related]
19. Delayed neuroprotection by riluzole against excitotoxic damage evoked by kainate on rat organotypic spinal cord cultures.
Mazzone GL; Nistri A
Neuroscience; 2011 Sep; 190():318-27. PubMed ID: 21689734
[TBL] [Abstract][Full Text] [Related]
20. Metabotropic glutamate receptor antagonists and agonists: potential neuroprotectors in diffuse brain injury.
Fei Z; Zhang X; Bai HM; Jiang XF; Wang XL
J Clin Neurosci; 2006 Dec; 13(10):1023-7. PubMed ID: 17113985
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
